CDC25A
MOLECULAR TARGETcell division cycle 25A
CDC25A (cell division cycle 25A) is targeted by 7 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CDC25A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | miltefosine | 5.81 | 334 |
| 2 | shikonin | 4.11 | 60 |
| 3 | lapachol | 3.76 | 42 |
| 4 | 2 methoxy 14 naphthoquinone | 2.77 | 15 |
| 5 | dysidiolide | 1.95 | 6 |
| 6 | plumbagin [Supplementary Concept] | 0.69 | 1 |
| 7 | Vitamin K 3 | 0.69 | 1 |
About CDC25A as a Drug Target
CDC25A (cell division cycle 25A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 7 compounds with documented CDC25A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CDC25A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.